Blume Capital Management, Inc. Exact Sciences Corp Transaction History

Blume Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$56.27 - $73.77 $6,189 - $8,114	-110 Reduced 52.38%	100 $6,000
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $18,977 - $25,722	210 New	210 $18,000
Q2 2019 Jul 29, 2019	SELL	$89.51 - $118.04 $18,797 - $24,788	-210 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$61.98 - $96.5 $13,015 - $20,265	210 New	210 $18,000

671

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.16B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.